REGENERX BIOPHARMACEUTICALS INC — Form D
REGENERX BIOPHARMACEUTICALS INC of BETHESDA, MD, a company, filed a Form D exempt-offering notice with the SEC on 2019-03-07. The offering totals $1.3M, of which $1.3M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2019-03-07
- Form: D
- Accession: 0001209191-19-017637
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $1.3M
- Amount sold: $1.3M
- Minimum investment: $100K
- Investors: 2
- Date of first sale: 2019-02-27
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-334305
Issuer
- Name: REGENERX BIOPHARMACEUTICALS INC
- CIK: 0000707511
- Entity type: Corporation
- Jurisdiction: DE
- Address: 3 BETHESDA METRO CENTER, BETHESDA, MD, 20814
- Phone: (301) 280-1992
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| Mauro Bove | Director | SAN DIEGO, CA |
| R. Don Elsey | Director | Rockville, MD |
| Allan L Goldstein | Director | Rockville, MD |
| Joseph Don McNay | Director | Rockville, MD |
| J.J. Finkelstein | Executive Officer | Rockville, MD |
| J.J. Finkelstein | Director | Rockville, MD |
| Joseph C McNay | Director | Boston, MA |
| R Don Elsey | Director | Rockville, MD |
| Mauro L Bove | Director | Rockville, MD |
| Allan Goldstein | Director | Purchase, NY |
| Joseph McNay | Director | San Antonio, TX |
| L. THOMPSON L BOWLES | Director | ROCKVILLE, MD |
| DAVID CROCKFORD | Executive Officer | ROCKVILLE, MD |
| C. NEIL LYONS | Executive Officer | ROCKVILLE, MD |
| R. DON L ELSEY | Director | ROCKVILLE, MD |
| L. Thompson Bowles | Director | Bethesda, MD |
| Richard Hindin | Director | Bethesda, MD |
| Jospeh McNay | Director | Bethesda, MD |
Other filings by this issuer (7)
More